SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Neumora Therapeutics Q3 net loss narrows 39% to $34.44 million

Neumora Therapeutics Q3 net loss narrows 39% to $34.44 million Neumora Therapeutics’ third-quart

NMRA

Related stories